The strong association between EoE and atopic conditions, coupled with the elevated levels of IL-4, IL-13, and other inflammatory mediators observed in EoE patients, provides a robust theoretical framework for DUPI’s efficacy [34,35,36]. Here, IL13 is linked to eosinophilic esophagitis.